Recombinant multi-species PHOX2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PHOX2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene contains a paired-like homeodomain most similar to that of the Drosophila aristaless gene product. The encoded protein plays a central role in development of the autonomic nervous system. It regulates the expression of tyrosine hydroxylase and dopamine beta-hydroxylase, two catecholaminergic biosynthetic enzymes essential for the differentiation and maintenance of the noradrenergic neurotransmitter phenotype. The encoded protein has also been shown to regulate transcription of the alpha3 nicotinic acetylcholine receptor gene. Mutations in this gene have been associated with autosomal recessive congenital fibrosis of the extraocular muscles. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ARIX,ARIX1 homeodomain protein,Aristaless homeobox protein homolog,Arix,CFEOM2,FEOM2,NCAM2,PHOX2A,PMX2A,Paired mesoderm homeobox protein 2A,Paired-like homeobox 2A,Phox2,Phox2a,Pmx2,Pmx2a,Px2a
Go
to PHOX2A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8715-Ag-1/ GM-Tg-hg-IP8715-Ag-2 | Human PHOX2A protein | Human |
| GM-Tg-rg-IP8715-Ag-1/ GM-Tg-rg-IP8715-Ag-2 | Rat PHOX2A protein | Rat |
| GM-Tg-mg-IP8715-Ag-1/ GM-Tg-mg-IP8715-Ag-2 | Mouse PHOX2A protein | Mouse |
| GM-Tg-cynog-IP8715-Ag-1/ GM-Tg-cynog-IP8715-Ag-2 | Cynomolgus/Rhesus macaque PHOX2A protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8715-Ag-1/ GM-Tg-felg-IP8715-Ag-2 | Feline PHOX2A protein | Feline |
| GM-Tg-cang-IP8715-Ag-1/ GM-Tg-cang-IP8715-Ag-2 | Canine PHOX2A protein | Canine |
| GM-Tg-bovg-IP8715-Ag-1/ GM-Tg-bovg-IP8715-Ag-2 | Bovine PHOX2A protein | Bovine |
| GM-Tg-equg-IP8715-Ag-1/ GM-Tg-equg-IP8715-Ag-2 | Equine PHOX2A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8715-Ag-1/ GM-Tg-hg-IP8715-Ag-2;
GM-Tg-rg-IP8715-Ag-1/ GM-Tg-rg-IP8715-Ag-2;
GM-Tg-mg-IP8715-Ag-1/ GM-Tg-mg-IP8715-Ag-2; GM-Tg-cynog-IP8715-Ag-1/ GM-Tg-cynog-IP8715-Ag-2; GM-Tg-felg-IP8715-Ag-1/ GM-Tg-felg-IP8715-Ag-2; GM-Tg-cang-IP8715-Ag-1/ GM-Tg-cang-IP8715-Ag-2; GM-Tg-bovg-IP8715-Ag-1/ GM-Tg-bovg-IP8715-Ag-2; GM-Tg-equg-IP8715-Ag-1/ GM-Tg-equg-IP8715-Ag-2 |
| Products Name | PHOX2A protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PHOX2A |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PHOX2A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.